Ropes & Gray Advises CANbridge Pharmaceuticals in Exclusive Worldwide License Agreement with UMass Chan Medical School

In The News
January 10, 2023

Ropes & Gray represented CANbridge Pharmaceuticals, a China-based biopharmaceutical company, in its exclusive worldwide license agreement with UMass Chan Medical School relating to the development and commercialization of a novel second-generation gene therapy for treatment of spinal muscular atrophy. The agreement was announced on January 4.

The CANbridge Pharmaceuticals team was led by IP transactions partner David McIntosh.